Literature DB >> 26027533

Neurodegenerative diseases: Repurposing for remyelination.

Megan Cully.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26027533     DOI： 10.1038/nrd4641

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.

Authors:  Fadi J Najm; Mayur Madhavan; Anita Zaremba; Elizabeth Shick; Robert T Karl; Daniel C Factor; Tyler E Miller; Zachary S Nevin; Christopher Kantor; Alex Sargent; Kevin L Quick; Daniela M Schlatzer; Hong Tang; Ruben Papoian; Kyle R Brimacombe; Min Shen; Matthew B Boxer; Ajit Jadhav; Andrew P Robinson; Joseph R Podojil; Stephen D Miller; Robert H Miller; Paul J Tesar
Journal:  Nature       Date:  2015-04-20       Impact factor: 49.962
  1 in total
  2 in total

1.  Miconazole alleviates peripheral nerve crush injury by mediating a macrophage phenotype change through the NF-κB pathway.

Authors:  Liangliang Zhang; Xiuju Chen; Zengyun Liu; Qingluan Han; Liguo Tang; Zhen Tian; Zhiyong Ren; Cunmin Rong; Hui Xu
Journal:  Brain Behav       Date:  2019-09-04       Impact factor: 2.708

2.  Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer's disease.

Authors:  Anna Rubinski; Nicolai Franzmeier; Anna Dewenter; Ying Luan; Ruben Smith; Olof Strandberg; Rik Ossenkoppele; Martin Dichgans; Oskar Hansson; Michael Ewers
Journal:  Alzheimers Res Ther       Date:  2022-09-24       Impact factor: 8.823
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.